Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC06: mFOLFOX vs ASC in Advanced Biliary Tract Cancer
NCT01926236Phase 3Completed
- Sponsor
- The Christie
- Start
- Feb 2014
- Primary completion
- Jan 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil in biliary tract cancer (BTC), sponsored by The Christie. Started Feb 2014; status: completed.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT01926236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01926236.